Difference between revisions of "Pharm Meeting Minutes 2021.03.17"
Jump to navigation
Jump to search
Michael tan (talk | contribs) |
Michael tan (talk | contribs) |
||
(24 intermediate revisions by 2 users not shown) | |||
Line 10: | Line 10: | ||
== Q1 13:00- 14:30 Change proposals & Medication Lists == | == Q1 13:00- 14:30 Change proposals & Medication Lists == | ||
+ | |||
+ | * Participants: | ||
+ | ** Leonidas Tzimis | ||
+ | ** Stephane Spahni | ||
+ | ** Jose Costa Teixeira | ||
+ | ** Michael Tan | ||
+ | ** Jurgen Brandstatter | ||
+ | ** Jacqueline Surugue | ||
+ | |||
===Change Proposals === | ===Change Proposals === | ||
+ | |||
+ | * Switzerland has recently organized a projectathon. A third projectathon is planned. This includes CDA and FHIR profiles. | ||
Overview: [https://drive.google.com/file/d/1d4TiC2h7qRiS7oEZVDNU2soQULycZyhQ/view?usp=sharing CP Overview] | Overview: [https://drive.google.com/file/d/1d4TiC2h7qRiS7oEZVDNU2soQULycZyhQ/view?usp=sharing CP Overview] | ||
:* [https://drive.google.com/file/d/1-48FLRY3BEnJuZ_nyz0Bfq1kFiOgWPYI/view?usp=sharing CP-PHARM-142] Proofreading / clarifications on CMPD, MTP, PADV profiles | :* [https://drive.google.com/file/d/1-48FLRY3BEnJuZ_nyz0Bfq1kFiOgWPYI/view?usp=sharing CP-PHARM-142] Proofreading / clarifications on CMPD, MTP, PADV profiles | ||
+ | :** Fixes something we have forgotten when we introduced COMMENT. | ||
+ | :** there are 2 definitions on XDS DocumentEntryType as a parameter. | ||
+ | |||
:* [https://drive.google.com/file/d/1WdPatA8OYpkD3uk0g1OeBHOrR-lfqBho/view?usp=sharing CP-PHARM-143] Align definitions of doseQuantity & rateQuantity (PRE profile) | :* [https://drive.google.com/file/d/1WdPatA8OYpkD3uk0g1OeBHOrR-lfqBho/view?usp=sharing CP-PHARM-143] Align definitions of doseQuantity & rateQuantity (PRE profile) | ||
+ | :** Dose and rate quantity is herited from PCC. Is it a quantity or a range. Which unit is allowed.There is a difference with PCC definition. | ||
:* [https://drive.google.com/file/d/1hzA_L9iXVIy3sMWqzWHsJdSgMphGLy7G/view?usp=sharing CP-PHARM-144] Forbid the use of ContextConductionInd (CMPD, MTP, PRE, DIS, PADV profiles) | :* [https://drive.google.com/file/d/1hzA_L9iXVIy3sMWqzWHsJdSgMphGLy7G/view?usp=sharing CP-PHARM-144] Forbid the use of ContextConductionInd (CMPD, MTP, PRE, DIS, PADV profiles) | ||
+ | :** Context conduction code. Relationships are inherited along to addtional attributes. There has been a lot of discussion within HL7. Proposed to discourage the use of context conduction | ||
:* [https://drive.google.com/file/d/1Yc4_QX9MaSEvYhNHE6gS5Hc3mJFUeOTE/view?usp=sharing CP-PHARM-145] Cross-community PHARM-1 (CMPD profile) | :* [https://drive.google.com/file/d/1Yc4_QX9MaSEvYhNHE6gS5Hc3mJFUeOTE/view?usp=sharing CP-PHARM-145] Cross-community PHARM-1 (CMPD profile) | ||
+ | :** A patient could live in another community. Need to forward the information to another community. Can reuse ITI38 and ITI18, but patient ID must be known. | ||
:* [https://drive.google.com/file/d/1kko76AnrwaramEwPsHovwj6veCNgT6td/view?usp=sharing CP-PHARM-146] New MHD-based transaction PHARM-5 (CMPD profile) | :* [https://drive.google.com/file/d/1kko76AnrwaramEwPsHovwj6veCNgT6td/view?usp=sharing CP-PHARM-146] New MHD-based transaction PHARM-5 (CMPD profile) | ||
+ | :** Need to support also RESTbased concepts which is then PHARM-5. Do we need to position it as a new approach to CMPD and not as temporarily solution? Is this a Swiss solution or an International approach? Jose is in a favor to keep low profile. | ||
+ | :** 3 possible solutions. | ||
+ | |||
:* [https://drive.google.com/file/d/1ejY288pLJOJVhVZkQmmvPklkDYGvxwgi/view?usp=sharing CP-PHARM-147] moodCode for patient-reported medications (MTP, PRE, DIS, PADV, CMA profiles) | :* [https://drive.google.com/file/d/1ejY288pLJOJVhVZkQmmvPklkDYGvxwgi/view?usp=sharing CP-PHARM-147] moodCode for patient-reported medications (MTP, PRE, DIS, PADV, CMA profiles) | ||
+ | :** In case a patient reports medication then it should be a event as mood code. In other cases it will be INT, whcih stands for intent. | ||
:* [https://drive.google.com/file/d/1m41hAFgwzLys6nmlibP-vg9IrbUJ5Ioi/view?usp=sharing OID Tree] | :* [https://drive.google.com/file/d/1m41hAFgwzLys6nmlibP-vg9IrbUJ5Ioi/view?usp=sharing OID Tree] | ||
− | + | :** Decide to leave the errors unchanged. Too much risk because of referenced chapters. | |
For information only: | For information only: | ||
:* [https://drive.google.com/file/d/1QwnGshWO9LYXLAZ9BY2-unaLBMbbZ4sL/view?usp=sharing CP-ITI-xxx] "RegistryStoredQueryResponse_Message" versus "RegistryStoredQuery_Response_Message" spelling | :* [https://drive.google.com/file/d/1QwnGshWO9LYXLAZ9BY2-unaLBMbbZ4sL/view?usp=sharing CP-ITI-xxx] "RegistryStoredQueryResponse_Message" versus "RegistryStoredQuery_Response_Message" spelling | ||
Line 28: | Line 49: | ||
=== Medication lists === | === Medication lists === | ||
+ | |||
+ | * In Belgium there is understanding that there are different needs for a medication list. | ||
+ | * We cannot force one formula for a medication list. | ||
+ | * The patient records accumulates all the information from different resources. | ||
+ | * Medication as a grouping item. It is more like a drill down mechanism. | ||
== 14:30- 15:00 Break == | == 14:30- 15:00 Break == | ||
Line 34: | Line 60: | ||
=== Participants === | === Participants === | ||
+ | |||
+ | * Michael Tan | ||
+ | * Jose Costa Teixeira | ||
+ | * Jurgen Brandstaetter | ||
+ | * Leonidas Tzimis | ||
+ | * Jacqueline Surugue | ||
+ | * Marc Robberecht | ||
+ | * Stéphane Spahni | ||
== Work items == | == Work items == | ||
− | * Review Doc from Chriss Carr | + | * Review Doc from Chriss Carr [https://docs.google.com/document/d/1kb4U4Yr7m4rJ34vOnezqs5nRKGYyBzPVnrNl-KECQtI/edit?ts=6050cc04 work item] |
− | |||
− | [https://docs.google.com/document/d/1kb4U4Yr7m4rJ34vOnezqs5nRKGYyBzPVnrNl-KECQtI/edit?ts=6050cc04 work item] | ||
== Logical Model == | == Logical Model == | ||
Line 59: | Line 91: | ||
https://github.com/gcangioli/vaccineCertificate | https://github.com/gcangioli/vaccineCertificate | ||
+ | * The Swiss model: | ||
+ | |||
+ | http://fhir.ch/ig/ch-vacd/index.html | ||
+ | |||
+ | |||
+ | Issue to be discussed: | ||
+ | * Site or route to be administered. Do we need to add site? | ||
+ | * Protocol and where to store number of vaccinations. Protocol in the IHE model is a reference. The standard resources is not. | ||
+ | * How to register that a patient only needs one injection. | ||
+ | * What value list do we use for status reason? | ||
+ | |||
+ | * Action: | ||
+ | ** Jose to contact Giorgio for the WHO model | ||
+ | ** Michael Contact Line Saele and Sylvia Thun | ||
+ | ** Stephane to contact HL7 Roeland Luyckx | ||
+ | ** Jose to contact HL7 PHER for Gemini | ||
+ | |||
+ | == Any other business == | ||
+ | * Schedule for IHE activities is not clear. Should use the Calendar. | ||
[[Pharmacy Technical Committee]] | [[Pharmacy Technical Committee]] | ||
[[Category: Minutes]] | [[Category: Minutes]] |
Latest revision as of 10:44, 17 March 2021
Meeting details
Location
Minutes
Q1 13:00- 14:30 Change proposals & Medication Lists
- Participants:
- Leonidas Tzimis
- Stephane Spahni
- Jose Costa Teixeira
- Michael Tan
- Jurgen Brandstatter
- Jacqueline Surugue
Change Proposals
- Switzerland has recently organized a projectathon. A third projectathon is planned. This includes CDA and FHIR profiles.
Overview: CP Overview
- CP-PHARM-142 Proofreading / clarifications on CMPD, MTP, PADV profiles
- Fixes something we have forgotten when we introduced COMMENT.
- there are 2 definitions on XDS DocumentEntryType as a parameter.
- CP-PHARM-142 Proofreading / clarifications on CMPD, MTP, PADV profiles
- CP-PHARM-143 Align definitions of doseQuantity & rateQuantity (PRE profile)
- Dose and rate quantity is herited from PCC. Is it a quantity or a range. Which unit is allowed.There is a difference with PCC definition.
- CP-PHARM-144 Forbid the use of ContextConductionInd (CMPD, MTP, PRE, DIS, PADV profiles)
- Context conduction code. Relationships are inherited along to addtional attributes. There has been a lot of discussion within HL7. Proposed to discourage the use of context conduction
- CP-PHARM-145 Cross-community PHARM-1 (CMPD profile)
- A patient could live in another community. Need to forward the information to another community. Can reuse ITI38 and ITI18, but patient ID must be known.
- CP-PHARM-146 New MHD-based transaction PHARM-5 (CMPD profile)
- Need to support also RESTbased concepts which is then PHARM-5. Do we need to position it as a new approach to CMPD and not as temporarily solution? Is this a Swiss solution or an International approach? Jose is in a favor to keep low profile.
- 3 possible solutions.
- CP-PHARM-143 Align definitions of doseQuantity & rateQuantity (PRE profile)
- CP-PHARM-147 moodCode for patient-reported medications (MTP, PRE, DIS, PADV, CMA profiles)
- In case a patient reports medication then it should be a event as mood code. In other cases it will be INT, whcih stands for intent.
- OID Tree
- Decide to leave the errors unchanged. Too much risk because of referenced chapters.
- CP-PHARM-147 moodCode for patient-reported medications (MTP, PRE, DIS, PADV, CMA profiles)
For information only:
- CP-ITI-xxx "RegistryStoredQueryResponse_Message" versus "RegistryStoredQuery_Response_Message" spelling
- CP-PCC-xxx Order of approachSiteCode, doseQuantity and rateQuantity varies --> may impact IHE PRE & MTP profiles
Medication lists
- In Belgium there is understanding that there are different needs for a medication list.
- We cannot force one formula for a medication list.
- The patient records accumulates all the information from different resources.
- Medication as a grouping item. It is more like a drill down mechanism.
14:30- 15:00 Break
Q2 15:00- 16:30 Vaccination Topics
Participants
- Michael Tan
- Jose Costa Teixeira
- Jurgen Brandstaetter
- Leonidas Tzimis
- Jacqueline Surugue
- Marc Robberecht
- Stéphane Spahni
Work items
- Review Doc from Chriss Carr work item
Logical Model
- WHO model
- European Model
- Belgian Model
- German Model
- The IHE Pharmacy material can be found here:
https://github.com/IHE/pharm-vaccination
- and
- the WHO FHIR material can be found in Github.
https://github.com/who-int/svc
https://github.com/gcangioli/vaccineCertificate
- The Swiss model:
http://fhir.ch/ig/ch-vacd/index.html
Issue to be discussed:
- Site or route to be administered. Do we need to add site?
- Protocol and where to store number of vaccinations. Protocol in the IHE model is a reference. The standard resources is not.
- How to register that a patient only needs one injection.
- What value list do we use for status reason?
- Action:
- Jose to contact Giorgio for the WHO model
- Michael Contact Line Saele and Sylvia Thun
- Stephane to contact HL7 Roeland Luyckx
- Jose to contact HL7 PHER for Gemini
Any other business
- Schedule for IHE activities is not clear. Should use the Calendar.